Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 confirmatory study of ATL-962 in obese patients with type 2 diabetes mellitus and dyslipidemia
jRCT2080220634Phase 3
- Sponsor
- Takeda
- Start
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in obesity, type 2 diabetes mellitus (T2DM), dyslipidemia and 1 more comparing ATL-962 with Placebo (2 arms).
02
Drugs
cetilistat
03
Conditions
obesitytype 2 diabetes mellitus (T2DM)dyslipidemiaAbdominal adiposity (ABCD)
Beyond the preview
Go deeper on jRCT2080220634.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220634.